131 related articles for article (PubMed ID: 33591178)
21. Coupling of prolyl peptide bond isomerization and Ca2+ binding in a C-type mannose-binding protein.
Ng KK; Weis WI
Biochemistry; 1998 Dec; 37(51):17977-89. PubMed ID: 9922166
[TBL] [Abstract][Full Text] [Related]
22. Cyclophilin D as a drug target.
Waldmeier PC; Zimmermann K; Qian T; Tintelnot-Blomley M; Lemasters JJ
Curr Med Chem; 2003 Aug; 10(16):1485-506. PubMed ID: 12871122
[TBL] [Abstract][Full Text] [Related]
23. Mechanistic insight into the role of transition-state stabilization in cyclophilin A.
Hamelberg D; McCammon JA
J Am Chem Soc; 2009 Jan; 131(1):147-52. PubMed ID: 19128175
[TBL] [Abstract][Full Text] [Related]
24. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.
Roth J; Koch P; Contente A; Dobbelstein M
Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217
[TBL] [Abstract][Full Text] [Related]
25. Ziploc-ing the structure 2.0: Endoplasmic reticulum-resident peptidyl prolyl isomerases show different activities toward hydroxyproline.
Ishikawa Y; Mizuno K; Bächinger HP
J Biol Chem; 2017 Jun; 292(22):9273-9282. PubMed ID: 28385890
[TBL] [Abstract][Full Text] [Related]
26. Role of Cysteine Residues in Regulation of Peptidyl-prolyl cis-trans Isomerase Activity of Wheat Cyclophilin TaCYPA-1.
Kaur G; Singh H; Kaur K; Roy S; Pareek A; Singh P
Protein Pept Lett; 2017; 24(6):551-560. PubMed ID: 28425861
[TBL] [Abstract][Full Text] [Related]
27. Molecular dynamics simulations of site point mutations in the TPR domain of cyclophilin 40 identify conformational states with distinct dynamic and enzymatic properties.
Gur M; Blackburn EA; Ning J; Narayan V; Ball KL; Walkinshaw MD; Erman B
J Chem Phys; 2018 Apr; 148(14):145101. PubMed ID: 29655319
[TBL] [Abstract][Full Text] [Related]
28. Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage.
Berger M; Stahl N; Del Sal G; Haupt Y
Mol Cell Biol; 2005 Jul; 25(13):5380-8. PubMed ID: 15964795
[TBL] [Abstract][Full Text] [Related]
29. Dynamical role of phosphorylation on serine/threonine-proline Pin1 substrates from constant force molecular dynamics simulations.
Velazquez HA; Hamelberg D
J Chem Phys; 2015 Feb; 142(7):075102. PubMed ID: 25702031
[TBL] [Abstract][Full Text] [Related]
30. Structural basis of interaction between dimeric cyclophilin 1 and Myb1 transcription factor in Trichomonas vaginalis.
Martin T; Lou YC; Chou CC; Wei SY; Sadotra S; Cho CC; Lin MH; Tai JH; Hsu CH; Chen C
Sci Rep; 2018 Apr; 8(1):5410. PubMed ID: 29615721
[TBL] [Abstract][Full Text] [Related]
31. p53 Protein is activated by Pin1: and also by Cu-SOD prion-like enzyme.
Wiseman A
Med Hypotheses; 2005; 65(1):32-4. PubMed ID: 15893113
[TBL] [Abstract][Full Text] [Related]
32. Computational perspective and evaluation of plausible catalytic mechanisms of peptidyl-prolyl cis-trans isomerases.
Ladani ST; Souffrant MG; Barman A; Hamelberg D
Biochim Biophys Acta; 2015 Oct; 1850(10):1994-2004. PubMed ID: 25585011
[TBL] [Abstract][Full Text] [Related]
33. Investigations of cyclophilin interactions with oligopeptides containing proline by affinity capillary electrophoresis.
Kiessig S; Thunecke F
J Chromatogr A; 2002 Dec; 982(2):275-83. PubMed ID: 12489884
[TBL] [Abstract][Full Text] [Related]
34. p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state.
Senturk S; Yao Z; Camiolo M; Stiles B; Rathod T; Walsh AM; Nemajerova A; Lazzara MJ; Altorki NK; Krainer A; Moll UM; Lowe SW; Cartegni L; Sordella R
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3287-96. PubMed ID: 25074920
[TBL] [Abstract][Full Text] [Related]
35. p53 binds the nuclear matrix in normal cells: binding involves the proline-rich domain of p53 and increases following genotoxic stress.
Jiang M; Axe T; Holgate R; Rubbi CP; Okorokov AL; Mee T; Milner J
Oncogene; 2001 Sep; 20(39):5449-58. PubMed ID: 11571642
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling.
Chen B; Xu M; Zhang H; Wang JX; Zheng P; Gong L; Wu GJ; Dai T
Biochem Biophys Res Commun; 2013 Aug; 437(4):526-31. PubMed ID: 23845906
[TBL] [Abstract][Full Text] [Related]
37. Suppression of apoptosis by cyclophilin D via stabilization of hexokinase II mitochondrial binding in cancer cells.
Machida K; Ohta Y; Osada H
J Biol Chem; 2006 May; 281(20):14314-20. PubMed ID: 16551620
[TBL] [Abstract][Full Text] [Related]
38. Kinetic analysis of cyclophilin-catalyzed prolyl cis/trans isomerization by dynamic NMR spectroscopy.
Kern D; Kern G; Scherer G; Fischer G; Drakenberg T
Biochemistry; 1995 Oct; 34(41):13594-602. PubMed ID: 7577948
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State.
Folda A; Citta A; Scalcon V; Calì T; Zonta F; Scutari G; Bindoli A; Rigobello MP
Sci Rep; 2016 Mar; 6():23071. PubMed ID: 26975474
[TBL] [Abstract][Full Text] [Related]
40. Proline isomerization of the immune receptor-interacting protein RIN4 by a cyclophilin inhibits effector-triggered immunity in Arabidopsis.
Li M; Ma X; Chiang YH; Yadeta KA; Ding P; Dong L; Zhao Y; Li X; Yu Y; Zhang L; Shen QH; Xia B; Coaker G; Liu D; Zhou JM
Cell Host Microbe; 2014 Oct; 16(4):473-83. PubMed ID: 25299333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
